Trials / Completed
CompletedNCT00729729
Pharmacokinetic Study for PCA Derivate Formulations
Phase 4, Three Way Cross-over, Pharmacokinetic Study for PCA Derivate Formulations in Healthy Subjects
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Hadassah Medical Organization · Academic / Other
- Sex
- Male
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
A comparative bioavailability study of PCA slow release versus immediate release formulations, after a single dose to fasting healthy subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | PCA | Placebo tablet, once |
| DRUG | PCA | PO, 700mg, once |
| DRUG | PCA | PO, 1000mg, once |
Timeline
- Start date
- 2008-07-01
- Primary completion
- 2009-02-01
- Completion
- 2009-12-01
- First posted
- 2008-08-07
- Last updated
- 2012-08-28
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT00729729. Inclusion in this directory is not an endorsement.